CECILIA CLAY: Open Payments
NPI 1205559879 · MOUNT PLEASANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 7 payments from 4 companies in 2025. Trend: 2023 $30 · 2024 $123 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: MOUNJARO, REXULTI, QULIPTA, CAPLYTA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
